Oral antidiabetic drug use in the elderly

Rubin Bressler, David G Johnson

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is a metabolic disease that is common in the elderly, and is characterised by insulin insufficiency and resistance. Measures such as bodyweight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase glucose disposal and decrease hepatic glucose output without causing hypoglycaemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, should improve blood glucose regulation in patients with NIDDM.

Original languageEnglish (US)
Pages (from-to)418-437
Number of pages20
JournalDrugs and Aging
Volume9
Issue number6
StatePublished - 1996

Fingerprint

troglitazone
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Pharmacology
Insulin
Acarbose
Dietary Carbohydrates
Glucose
Metformin
Metabolic Diseases
Hypoglycemia
Insulin Resistance
Blood Glucose
Exercise
Liver
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Geriatrics and Gerontology

Cite this

Oral antidiabetic drug use in the elderly. / Bressler, Rubin; Johnson, David G.

In: Drugs and Aging, Vol. 9, No. 6, 1996, p. 418-437.

Research output: Contribution to journalArticle

Bressler, R & Johnson, DG 1996, 'Oral antidiabetic drug use in the elderly', Drugs and Aging, vol. 9, no. 6, pp. 418-437.
Bressler, Rubin ; Johnson, David G. / Oral antidiabetic drug use in the elderly. In: Drugs and Aging. 1996 ; Vol. 9, No. 6. pp. 418-437.
@article{b356bef8359d4392a1fcac6808058f55,
title = "Oral antidiabetic drug use in the elderly",
abstract = "Non-insulin-dependent diabetes mellitus (NIDDM) is a metabolic disease that is common in the elderly, and is characterised by insulin insufficiency and resistance. Measures such as bodyweight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase glucose disposal and decrease hepatic glucose output without causing hypoglycaemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, should improve blood glucose regulation in patients with NIDDM.",
author = "Rubin Bressler and Johnson, {David G}",
year = "1996",
language = "English (US)",
volume = "9",
pages = "418--437",
journal = "Drugs and Aging",
issn = "1170-229X",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Oral antidiabetic drug use in the elderly

AU - Bressler, Rubin

AU - Johnson, David G

PY - 1996

Y1 - 1996

N2 - Non-insulin-dependent diabetes mellitus (NIDDM) is a metabolic disease that is common in the elderly, and is characterised by insulin insufficiency and resistance. Measures such as bodyweight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase glucose disposal and decrease hepatic glucose output without causing hypoglycaemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, should improve blood glucose regulation in patients with NIDDM.

AB - Non-insulin-dependent diabetes mellitus (NIDDM) is a metabolic disease that is common in the elderly, and is characterised by insulin insufficiency and resistance. Measures such as bodyweight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase glucose disposal and decrease hepatic glucose output without causing hypoglycaemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, should improve blood glucose regulation in patients with NIDDM.

UR - http://www.scopus.com/inward/record.url?scp=0030463794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030463794&partnerID=8YFLogxK

M3 - Article

C2 - 8972242

AN - SCOPUS:0030463794

VL - 9

SP - 418

EP - 437

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 6

ER -